What's the cheapest legal way to get semaglutide?
Brand Wegovy costs $1,300+/month without insurance. Manufacturer coupons, telehealth flat-rates, and compounded options can cut that dramatically — here's how each works.
Updated May 20, 2026 · 5 min read
The cheapest legal route depends on your insurance status and which type of semaglutide you're eligible for. For people with commercial insurance, the Novo Nordisk savings card can bring Wegovy down to $25/month. Without insurance, compounded semaglutide from a licensed 503A pharmacy — where legally available — is typically the lowest-cost option at $100–300/month.
With Insurance: The Manufacturer Savings Card
Novo Nordisk's Wegovy Savings Offer is the first stop for commercially insured patients. If your insurance covers Wegovy, the savings card can reduce your out-of-pocket cost to $0 for the first month and $25/month after that, with an annual cap on total savings.
Eligibility requirements:
- Must have commercial or private insurance (not Medicare or Medicaid)
- Insurance must cover Wegovy (this varies widely by plan)
- You must be a US resident
The card is available through the WegovySavings.com page and is processed at the pharmacy. It doesn't require you to apply in advance — your pharmacist typically applies it automatically.
If your insurance doesn't cover Wegovy: The savings card doesn't help much. At full retail, Wegovy is roughly $1,300–$1,500/month without a benefit. Pharmacy discount cards like GoodRx bring this down slightly for the brand name, but not dramatically — brand GLP-1 pens don't discount well through the standard coupon networks.
For Ozempic specifically: Novo Nordisk also has savings programs for Ozempic (the diabetes-indication version). Some providers prescribe Ozempic off-label for weight management, particularly for patients who qualify only for the diabetes indication. The same savings card applies.
Without Insurance: Telehealth Flat-Rate Programs
Several telehealth platforms offer bundled semaglutide programs that include the consultation, prescription, and medication at a flat monthly rate. These typically run $200–350/month and often use compounded semaglutide from affiliated pharmacies.
How these programs work:
- You complete an online intake (health history, weight, goals)
- A licensed provider reviews it and issues a prescription
- Medication is shipped directly to you monthly
Common platforms in this space include Hims, Ro, Sequence, and others. Pricing varies and changes frequently — the telehealth market has been competitive and promotional rates come and go. The key things to verify before enrolling:
- Is the pharmacy they use a licensed 503A compounding pharmacy (state-licensed) or a 503B outsourcing facility (FDA-registered)?
- Are you getting the peptide as a vial (requiring reconstitution) or a pre-filled syringe?
- What is the cancellation policy?
Compounded Semaglutide: The Legal Landscape as of 2026
Compounded semaglutide is where most of the cost savings are, and where the regulatory picture is most complicated.
Background: The FDA compounding exemption allowed pharmacies to compound semaglutide while the brand was on the official drug shortage list. In early 2025, the FDA removed semaglutide from the shortage list. This triggered different rules for different types of pharmacies:
| Pharmacy type | Post-shortage status |
|---|---|
| 503B outsourcing facilities | Cannot compound semaglutide for general distribution (shortage exemption ended) |
| 503A pharmacies | Can still compound for specific patients with a valid prescription, subject to state law and patient-specific need |
In practice, as of 2026, many 503A pharmacies continue to compound semaglutide under patient-specific prescription rules. The FDA has issued warning letters to facilities that appear to be operating at scale under the 503A banner rather than for individualized patients.
What "legal" means here is genuinely context-dependent. A 503A pharmacy filling a patient-specific compounded semaglutide prescription for a patient where the brand is unavailable or cost-prohibitive is in a different legal position than a high-volume fulfillment operation. The line between them is actively being litigated.
If you're using compounded semaglutide, look for:
- A pharmacy with a state license visible on their website and verifiable in your state's pharmacy board database
- A prescription from a licensed clinician — not a self-directed order
- Certificate of analysis (COA) for each batch, showing purity and concentration testing
- Clear dosing instructions in mg (not just units)
Our compounded semaglutide safety guide covers the full vetting process.
Other Options Worth Knowing About
GoodRx for Ozempic: GoodRx can meaningfully reduce the price of Ozempic at some pharmacies, particularly independent pharmacies and Costco. Prices vary significantly by zip code and pharmacy — check multiple options before filling.
Patient assistance programs: Novo Nordisk's NovoCare program provides Wegovy and Ozempic at low or no cost for eligible uninsured patients who meet income criteria. Applications go through the NovoCare website. Processing can take 2–4 weeks.
Employer-sponsored benefits: Some large employers have begun covering GLP-1s through expanded benefits. Worth checking your Summary of Benefits explicitly — coverage for "obesity medications" or "weight management medications" is the phrase to look for.
Insurance appeals: If your insurer denied Wegovy coverage and you have a qualifying BMI plus a comorbidity, a prior authorization appeal with clinical documentation often succeeds. Your prescriber can assist — it requires a letter and sometimes a peer-to-peer call with the insurer's medical reviewer.
What to Avoid
Peptide research companies: Semaglutide sold as a "research chemical" or "for laboratory use only" is not meant for human injection. These products are unregulated, untested for human use, and potentially hazardous. This category includes vendors that ship from overseas without any prescription requirement.
Unverified online pharmacies: If a pharmacy requires no prescription, ships internationally without disclosure, or advertises prices dramatically below the 503A compounded market rates, the source and quality are not verifiable.
The cost problem with semaglutide is real — the access gap between people who can and can't afford it is one of the major stories of this drug class. But the workarounds that skirt the prescription and quality requirements create a different set of risks.